Yeganeh-Hajahmadi Mahboobeh, Najafipour Hamid, Rostamzadeh Farzaneh, Naghibzadeh-Tahami Ahmad
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Science, Kerman, Iran.
Diabetol Metab Syndr. 2021 Oct 20;13(1):115. doi: 10.1186/s13098-021-00736-2.
Hypertension and diabetes are among the most important risk factors of cardiovascular diseases. Klotho and SIRT1 are known as anti-aging factors with beneficial effects on cardiovascular system. In this study we investigated the serum Klotho and SIRT1 levels in pre-diabetic and pre-hypertensive individuals and then in diabetic and hypertensive patients to see their relationship with these diseases.
229 individuals divided into six groups with similar gender and age distribution 1-Control (normal BP and FBS) 2-pre-diabetic (FBS between 100 and 125 mg/dl) 3-diabetic (FBS ≥ 126 mg/dl), 4-pre-hypertensive (SBP 120-139 or DBP 80-89 mm Hg) 5-hypertensive (SBP ≥ 140 or DBP ≥ 90 mm Hg), and 6-patients with combined hypertension/diabetes. Serum levels of Klotho and SIRT1 were measured by ELISA method.
Serum Klotho and STRT1 levels decreased in pre-diabetes and returned to normal in diabetic patients. Their concentration increased in pre-hypertension and recovered to normal in hypertension. In the physiologic range of FBS there is a negative correlation between Klotho and SIRT1 with FBS. When pathologic ranges of FBS added to analysis, the negative correlation abolished/U shaped. Also an inverse U shape correlation observed between Klotho and SIRT1 with MAP in the range of normal to hypertensive BP levels. There was an overall positive relationship between the serum levels of Klotho and SIRT1 themselves.
The serum levels of the anti-aging proteins Klotho and SIRT1 increases or reduces at the onset of the disease, as a compensatory mechanism, but as the disease progresses their level recovers.
高血压和糖尿病是心血管疾病最重要的危险因素。α-klotho蛋白(Klotho)和沉默信息调节因子1(SIRT1)被认为是对心血管系统具有有益作用的抗衰老因子。在本研究中,我们调查了糖尿病前期和高血压前期个体以及糖尿病和高血压患者的血清Klotho和SIRT1水平,以观察它们与这些疾病的关系。
229名个体被分为六组,性别和年龄分布相似:1-对照组(血压和空腹血糖正常);2-糖尿病前期(空腹血糖在100至125mg/dl之间);3-糖尿病患者(空腹血糖≥126mg/dl);4-高血压前期(收缩压120 - 139或舒张压80 - 89mmHg);5-高血压患者(收缩压≥140或舒张压≥90mmHg);6-高血压合并糖尿病患者。采用酶联免疫吸附测定(ELISA)法测量血清Klotho和SIRT1水平。
糖尿病前期血清Klotho和SIRT1水平降低,糖尿病患者则恢复正常。高血压前期其浓度升高,高血压患者恢复正常。在空腹血糖的生理范围内,Klotho和SIRT1与空腹血糖呈负相关。当将空腹血糖的病理范围纳入分析时,负相关消失/呈U形。在正常血压至高血压血压水平范围内,Klotho和SIRT1与平均动脉压(MAP)之间也观察到反U形相关性。血清Klotho和SIRT1水平之间总体呈正相关。
抗衰老蛋白Klotho和SIRT1的血清水平在疾病发作时作为一种代偿机制会升高或降低,但随着疾病进展其水平会恢复。